Comparative Effectiveness and Safety of Cognitive Enhancers for Treating Alzheimer’s Disease: Systematic Review and Network Metaanalysis

Tricco, Andrea C., Ashoor, Huda M., Soobiah, Charlene, Rios, Patricia, Veroniki, Areti Angeliki, Hamid, Jemila S., Ivory, John D., Khan, Paul A. +9 more·2018·Journal of the American Geriatrics Society
DOI 10.1111/jgs.15069

Cited by (136)

Items 101–136 of 136

  1. Comment on “The Relationship Between Antipsychotics, Cognitive Enhancers, and Major Adverse Cardiovascular/Cerebrovascular Events (MACCE) in Older Adults with Behavioral and Psychological Symptoms of Dementia”
    H. Lenoir · 2024 · Drugs & Aging
  2. The problem of multiple adjustments in the assessment of minimal clinically important differences
    Fabricio Ferreira de Oliveira · 2025 · Alzheimer s & Dementia Translational Research & Clinical Interventions
  3. Cholinesterase inhibitors in dementias
    Patrizia Mecocci, Lucia Paolacci, Virginia Boccardi · 2020 · Elsevier eBooks
  4. A Global Review on Alzheimer’s Disease
    Natarajan. P, P Mumthaj., Vijay. J, V Gokul. · 2021 · International Journal of Pharmaceutical Sciences Review and Research
  5. Chapter 20. Psychopharmacology
    Benoit H. Mulsant, Bruce G. Pollock · 2022 · American Psychiatric Association Publishing eBooks
  6. Exploring the Potential of Herbal Compounds as Autophagy Modulators in Alzheimer's Disease: A Comprehensive Review
    Ekta Yadav, Ashok Kumar Mandal, Ajay Kumar Sah, Sandesh Poudel, Prateek Pathak, Habibullah Khalilullah, Mariusz Jaremko, Abdul-Hamid M. Emwas, Pankajkumar S. Yadav, Amita Verma · 2024 · CNS & Neurological Disorders - Drug Targets
  7. A Review Article on Current Therapeutic Strategies and Future Directions in the Treatment of Alzheimer’s Disease.
    Poonam Gupta · 2024 · African Journal of Biomedical Research
  8. Representing the Social Problem of Dementia: Reflexions on Carol Bacchi’s What Is the Problem Represented to Be Approach
    Steve Iliffe, Jill Manthorpe · 2025 · Social Policy and Society
  9. Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
    Arman Yurisaldi Saleh, Dwi Arwandi Yogi Saputra, Riezky Valentina, Tirta Darmawan Susanto · 2025 · F1000Research
  10. Edible Flowers’ Bioactive Compounds: Nutraceutical Aspect and Industrial Food Exploration
    Chalermchai Wongs‐Aree, Mantana Buanong · 2026 · Advances in olericulture
  11. Integrative Analysis of Pharmacological and Non-pharmacological Interventions in Alzheimer’s Dementia
    Digantkumar Patel, Tejas Patel, Parag N Patel · 2026 · Cureus
  12. Advances in the treatment of Alzheimer’s disease
    Rezzan Temelli Goceroglu, Ahmet Hacımüftüoğlu · 2026 · Frontiers in Pharmacology
  13. Anti-dementia Medication
    Vesna Jelić, Bengt G. Winblad · 2021 · Springer eBooks
  14. Alzheimer’s Disease and Other Dementias
    Ian Curtis Neel · 2022 · Springer eBooks
  15. Ginkgo Biloba as a niche theme cognitive enhancer agent, 1420 dokumen of Scopus database. A bibliometric study from 1988 to 2024
    Arman Yurisaldi Saleh, Dwi Arwandi Yogi Saputra, Riezky Valentina, Tirta Darmawan Susanto · 2025 · F1000Research
  16. Neuroinflammation in Alzheimer's Disease Continuum
    Aslihan Taskiran Sag, Müge Yemişçi · 2020 · Neurological Sciences and Neurophysiology
  17. Oldest Old Patients Should be Recruited More in Clinical Trials of Dementia
    Young Ho Park · 2018 · Journal of Korean Medical Science
  18. A causal model to explain data reuse in science: a study in health disciplines
    María Inmaculada Aleixos Borrás · 2020
  19. Management of Alzheimer's disease
    Michael K. Rainer, Hermann AM Mucke · 2019 · Hamdan Medical Journal
  20. Role of Cognitive Function in Managing People with Diabetes
    Tamsin Santos, Chelsea Baird, Sally Eastwood, Kerrie Shiell, Joseph Ibrahim · 2024 · Wiley eBooks
  21. Perfil de seguridad y satisfacción con la combinación fija de memantina-donepezilo en pacientes con diagnóstico de alzheimer moderado a severo - Safety and satisfaction profile with the fixed combination of memantine-donepezil in patients diagnosed with moderate to severe Alzheimer's disease
    Jorge Moncayo-Gaete, Enerys Mendoza-Tirado, Lissette Duque, Fabian Guapisaca, Margarita Rosa Aveiga Narváez, Soledad Chiriboga-Lozada, Francisco Romero-Cortez, Sandro Patricio Romero Proaño · 2024 · Revista de la Facultad de Ciencias Médicas (Quito)
  22. Efficacy of combination therapy with Donepezil and Memantine in Alzheimer and mixed dementia: A comparative study
    O. Crețu, Marius Cocu, Denisa Oana Zelinschi, Elena-Rodica Popescu · 2024 · Bulletin of Integrative Psychiatry
  23. Clinical trials
    Sarah Gregory, Stina Saunders, Craig William Ritchie · 2025 · Elsevier eBooks
  24. Healthcare related costs associated with donepezil use in patients with very mild dementia due to Alzheimer's disease: A retrospective observational study
    Sun-Wung Hsieh, Chen-Yang Hsiao, Yuan-Han Yang, Hui-Min Hsieh · 2025 · Journal of Alzheimer's disease reports
  25. Additional file 1 of Primary care physician volume and quality of care for older adults with dementia: a retrospective cohort study
    Natasha E. Lane, Vicki Ling, Glazier, Richard H., Stukel, Thérèse A. · 2021 · Figshare
  26. Additional file 1 of Patterns of use of symptomatic treatments for Alzheimer's disease dementia (AD)
    Julia Richmond DiBello, Lu, Yifei, Jina Swartz, Edward A. Bortnichak, Liaw, Kai-Li, Wenjun Zhong, Xinyue Liu · 2024 · Figshare
  27. Additional file 3 of Primary care physician volume and quality of care for older adults with dementia: a retrospective cohort study
    Natasha E. Lane, Vicki Ling, Glazier, Richard H., Stukel, Thérèse A. · 2021 · Figshare
  28. Additional file 2 of Primary care physician volume and quality of care for older adults with dementia: a retrospective cohort study
    Natasha E. Lane, Vicki Ling, Glazier, Richard H., Stukel, Thérèse A. · 2021 · Figshare
  29. Exploring Adjunctive Novel Therapeutic Approach of KarXT (Xanomeline‐Trospium Chloride) for Managing Psychotic Symptoms in Patients With Schizophrenia and Alzheimer's Disease
    Ashir Kanwal, Babar Azeem, Hania Nasir, Fatima Mumtaz, Nauman Ashraf, Mohammed Hammad Jaber Amin, Warisha Kanwal, Bilal Wazir Khan · 2026 · Brain and Behavior
  30. Trends in First-Time Symptomatic Antidementia Drug Dispensations to Home-Dwelling People in Norway: A Nationwide Register-Based Study
    Torunn Gudmestad Øvrebø, Anita Lenora Sunde, Arvid Rongve, Svein Reidar Kjosavik, Ingvild Dalen, Ragnhild Oesterhus · 2026 · Drugs - Real World Outcomes
  31. Re-Purposing a Rho-Associated Coiled-Coil Kinase (ROCK) Inhibitor for Alzheimer’s Disease
    Xavier Cambi, Zhiqing Liu, Kevin Guo, Weiming Xia · 2026 · Journal of Clinical Medicine
  32. Interactions in psychosocial interventions in dementia care: A systematic review protocol
    Ivy Meihua Su, Keyu Li, Winsy Wing Sze Wong · 2026 · PLoS ONE
  33. Comparative efficacy and safety of pathway-targeted pharmacotherapies for Alzheimer’s disease: A systematic review and network meta-analysis of phase III trials
    Yucen Wu, Yiming Di, H W Wang, L Wang, Junchao Zhang, Yu Zhang, Diyang Lyu · 2026 · Ageing Research Reviews
  34. Pharmacotherapy for Alzheimer's Disease and Dementias in Long-Term Care: A Real-World EHR Study
    Tyler M. Saumur, Huda Ashraf, Katherine E. Mathers, Brittin Wagner · 2026 · Journal of the American Medical Directors Association
  35. BindingDB Entry 50007946: Discovery of Novel, Potent, Brain-Permeable, and Orally Efficacious Positive Allosteric Modulator of α7 Nicotinic Acetylcholine Receptor [4-(5-(4-Chlorophenyl)-4-methyl-2-propionylthiophen-3-yl)benzenesulfonamide]: Structure-Activity Relationship and Preclinical Characterization.
    BindingDB · 2021 · UC San Diego
  36. BindingDB Entry 50007234: Design and development of some phenyl benzoxazole derivatives as a potent acetylcholinesterase inhibitor with antioxidant property to enhance learning and memory.
    BindingDB · 2021 · UC San Diego